Related Experiment Video
Updated: Jan 20, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Effects of culture method on response to EGFR therapy in head and neck squamous cell carcinoma cells
Jose M Ayuso1,2,3, Ross Vitek2,3, Adam D Swick4
1Morgridge Institute for Research, 330N Orchard street, Madison, WI, USA.
Abstract:
The EGFR pathway plays a critical role in head and neck squamous cell carcinoma (HNSCC). Targeted therapies against the EGFR are utilized as a treatment for HNSCCC. However, patient response is heterogeneous and molecular biomarkers are lacking to predict patient response. Therefore, functional assays where drug response is directly evaluated in tumor cells are an interesting alternative. Previous studies have shown that experimental conditions modify the drug response observed in functional assays. Thus, in this work the influence of the culture environment on response to Cetuximab (EGFR monoclonal antibody) and AZD8055 (mTOR inhibitor) was evaluated. HNSCC UM-SCC-1 and UM-SCC-47 cells were cultured in 2D monoculture and compared with: 2D co-culture with cancer-associated fibroblasts (CAF); 3D culture in collagen hydrogels; and 3D culture in tumor spheroids. The results showed UM-SCC-1 drug response significantly changed in the different culture environments; leading to an increase in drug resistance in the CAF co-culture and the 3D spheroids. Conversely, UM-SCC-47 exhibited a more constant drug response across culture conditions. In conclusion, this work highlights the importance of culture conditions that modulate response to EGFR pathway inhibition.
Insights
Culture conditions significantly impact head and neck squamous cell carcinoma (HNSCC) treatment response. This study reveals how different environments affect drug efficacy, highlighting the need for optimized assays for targeted therapies.
Area of Science:
- Oncology
- Cell Biology
- Cancer Research
Background:
- The Epidermal Growth Factor Receptor (EGFR) pathway is crucial in head and neck squamous cell carcinoma (HNSCC).
- Targeted EGFR therapies are used for HNSCC, but patient responses vary, and predictive biomarkers are scarce.
- Functional assays evaluating drug response directly in tumor cells offer an alternative, but experimental conditions can influence outcomes.
Purpose of the Study:
- To investigate how different culture environments affect the response of HNSCC cells to EGFR pathway inhibitors.
- To compare drug responses in 2D monoculture, 2D co-culture with cancer-associated fibroblasts (CAF), 3D collagen hydrogels, and 3D tumor spheroids.
Main Methods:
- HNSCC cell lines UM-SCC-1 and UM-SCC-47 were cultured under various conditions: 2D monoculture, 2D co-culture with CAFs, and 3D cultures (collagen hydrogels, tumor spheroids).
- Response to Cetuximab (anti-EGFR antibody) and AZD8055 (mTOR inhibitor) was evaluated in each culture setting.
Main Results:
- UM-SCC-1 cells showed significantly altered drug responses depending on the culture environment, with increased resistance observed in CAF co-cultures and 3D spheroids.
- UM-SCC-47 cells displayed a more consistent drug response across different culture conditions.
- Culture environment modulated the efficacy of EGFR pathway inhibition.
Conclusions:
- Culture conditions critically influence drug response in HNSCC functional assays.
- The choice of culture model is essential for accurately assessing the efficacy of targeted therapies like EGFR inhibitors.
- These findings underscore the need for culture systems that better mimic the tumor microenvironment to predict clinical response.
Related Concept Videos
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
08:59A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
11:28Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
10:43Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

